GRP
MRNA icon

Global Retirement Partners’s Moderna MRNA Stock Holding History

Global Retirement Partners’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$189K Buy
+2,702
New +$140K ﹤0.01% 1617
2025
Q4 		$85.3K Buy
2,893
+17
+0.6% +$462 ﹤0.01% 2007
2025
Q3 		$74.3K Buy
2,876
+1,107
+63% +$30.9K ﹤0.01% 1679
2025
Q2 		$48.8K Buy
+1,769
New +$46.6K ﹤0.01% 1785
2024
Q4 		$97K Sell
2,334
-292
-11% -$14K ﹤0.01% 1284
2024
Q3 		$175K Sell
2,626
-1,684
-39% -$155K 0.01% 968
2024
Q2 		$512K Sell
4,310
-1,845
-30% -$233K 0.02% 607
2024
Q1 		$656K Buy
6,155
+2,971
+93% +$299K 0.02% 463
2023
Q4 		$325K Buy
3,184
+327
+11% +$27.5K 0.01% 586
2023
Q3 		$298K Buy
2,857
+90
+3% +$10K 0.02% 550
2023
Q2 		$336K Sell
2,767
-2
-0.1% -$267 0.02% 535
2023
Q1 		$360K Buy
2,769
+80
+3% +$13.2K 0.02% 501
2022
Q4 		$483K Buy
2,689
+559
+26% +$91.4K 0.03% 377
2022
Q3 		$320K Buy
2,130
+213
+11% +$32.3K 0.02% 448
2022
Q2 		$274K Sell
1,917
-13
-0.7% -$1.86K 0.02% 491
2022
Q1 		$255K Buy
+1,930
New +$325K 0.02% 502
2021
Q4 		– Sell
-865
Closed -$333K – 1209
2021
Q3 		$333K Buy
865
+565
+188% +$208K 0.03% 372
2021
Q2 		$70K Buy
300
+21
+8% +$3.75K 0.01% 740
2021
Q1 		$37K Sell
279
-116
-29% -$16.8K ﹤0.01% 898
2020
Q4 		$41K Sell
395
-82
-17% -$8.3K 0.01% 797
2020
Q3 		$34K Buy
477
+60
+14% +$4.18K 0.01% 743
2020
Q2 		$27K Sell
417
-723
-63% -$39.6K ﹤0.01% 808
2020
Q1 		$34K Buy
+1,140
New +$26.2K 0.01% 659
2019
Q3 		– Sell
-850
Closed -$12K – 1658
2019
Q2 		$12K Hold
850
– – ﹤0.01% 1063
2019
Q1 		$17K Buy
+850
New +$15.8K ﹤0.01% 884

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Global Retirement Partners's MRNA Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Moderna (MRNA) in Q2 2026: 2,702 shares worth $189K. The stake represents ﹤0.01% of the portfolio and ranks #1617 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in MRNA as recently as Q4 2025.

Global Retirement Partners first reported a position in MRNA in Q1 2019 and has held it in 25 quarters since. The position peaked at $656K in Q1 2024. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Global Retirement Partners held 2,702 shares of Moderna worth $189K as of Q2 2026.
  • Moderna was a new Global Retirement Partners position in Q2 2026.
  • Moderna made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #1617 holding.
  • Global Retirement Partners first reported a position in Moderna in Q1 2019 and has held it in 25 quarters since.
  • Global Retirement Partners's Moderna position peaked at $656K in Q1 2024.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.